The critical role of bisphosphonates to target bone cancer metastasis: an overview. - Wikidata - wikimedia - TriplyDB

The critical role of bisphosphonates to target bone cancer metastasis: an overview.

The critical role of bisphosphonates to target bone cancer metastasis: an overview.

http://www.wikidata.org/entity/Q38247428

about

Pre-Assembly of Near-Infrared Fluorescent Multivalent Molecular Probes for Biological Imaging Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.Bisphosphonates in the Treatment of Patients With Metastatic Breast, Lung, and Prostate Cancer: A Meta-Analysis.Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model Potential options for managing LOX+ ER- breast cancer patients Polysaccharides based nanomaterials for targeted anti-cancer drug delivery.Zoledronic acid induces apoptosis via stimulating the expressions of ERN1, TLR2, and IRF5 genes in glioma cells.Development of nanomaterials for bone-targeted drug delivery.Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cells.Zoledronate-Associated Osteonecrosis of the Jaw in a Dog with Appendicular Osteosarcoma Bisphosphonate-Functionalized Hydroxyapatite Nanoparticles for the Delivery of the Bromodomain Inhibitor JQ1 in the Treatment of Osteosarcoma.Zoledronic Acid Regulates Autophagy and Induces Apoptosis in Colon Cancer Cell Line CT26.Redox and pH dual sensitive bone targeting nanoparticles to treat breast cancer bone metastases and inhibit bone resorption.

P2860

Q28829172-F930730D-0476-4EC8-861B-F6C51EB35794 Q36034236-13F8BE41-D2DF-4AB3-8AD7-D2D854A99CEE Q36299278-20CEEE0C-0071-485F-9A9A-8050185428CD Q36847530-F8008E66-646D-49BE-8499-45CE59FC7E68 Q37362796-4AF92C38-F811-49F7-A4FB-9427A7DC4A7F Q38794160-52A1A0C0-8C8A-4CA2-93F9-5EA88687DAC1 Q38813588-8A3A9F5B-33B0-4F89-B6CF-D06E6A7D5721 Q39294078-FE7ED4AD-6846-42D3-89BE-D0B697B76A3D Q42335714-A7242A25-1662-46B0-9C0F-C36824F07230 Q42376504-EF530045-C713-442C-8FFA-916E23E7857E Q46924536-B81C8DD1-A352-4D0D-9E79-3BB9A94F9730 Q49865478-B848DBE5-F513-4B7F-BCCA-6E42B529ABB1 Q50648312-E915A1F9-9648-4C2B-8053-050F5FDBC6AF

P2860

The critical role of bisphosphonates to target bone cancer metastasis: an overview.

http://www.wikidata.org/entity/Q38247428

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

The critical role of bisphosphonates to target bone cancer metastasis: an overview.

@en

type

label

The critical role of bisphosphonates to target bone cancer metastasis: an overview.

@en

prefLabel

The critical role of bisphosphonates to target bone cancer metastasis: an overview.

@en

P1433

Q38247428-4295CEB3-A5D7-44A9-9CD0-1F02712E2E55

P1476

Q38247428-E70BA1C4-019F-45DB-9F8E-18B43390D608

P2093

Q38247428-5D659245-CB54-4F3E-92D3-B87C4CC25107

Q38247428-97BC336B-A7CE-4611-80BE-3961C6A33024

Q38247428-9E6F5238-6092-40AD-9F7B-D8B7EBA2B04A

Q38247428-C4E6EA4D-2800-4F39-9B97-D6D3FF127274

Q38247428-FF313677-43FC-4E1E-BC49-74571EB6A49B

P2860

Q38247428-0316CB09-120B-44A7-BE0C-75EB6DAA4992

Q38247428-0370233B-B0CD-40AA-93AA-9CAB7355E0B3

Q38247428-05FE56E9-2179-4C43-8858-62672B86D710

Q38247428-08EB7017-5B2C-4F19-A572-3285D4F82577

Q38247428-094DBA34-4601-4D78-AA2C-C02DFF58AA85

Q38247428-0B240684-573E-48E5-A94E-86E0DA69F62E

Q38247428-1266DB6A-0CE3-4C8D-8304-DE33C1E144CD

Q38247428-14086DCD-F1B9-4EE0-A7DA-FF827F4E8807

Q38247428-155CED75-7B83-45AD-8F93-62698D64BE58

Q38247428-195D846E-471E-4DF5-B089-E0BE5032260B

P304

Q38247428-B53FFDB7-01D6-4BB9-BE71-F39BA164C568

P31

Q38247428-0A32EEA3-5F25-45B7-89DD-785200D4D165

Q38247428-3de6c349-ce25-4557-926a-433f9dbd60f9

P356

Q38247428-85A33D44-2A6E-44B5-8A54-2967EE0BFA23

P433

Q38247428-CEF125BC-6577-4CCC-B3AC-B1195CD8A01C

P478

Q38247428-7C8AC826-7E51-41A2-8E8D-8D9A550EBF19

P50

Q38247428-6F0CCFFB-A3EB-4B4A-A4E6-83F0895D42D5

P577

Q38247428-E1B978AA-950B-441F-8C11-3F33AEF19787

P698

Q38247428-561ABFF6-52F5-4F5F-B4BF-FA14615FFB9A

P356

1061186X.2014.950668

P1433

Journal of Drug Targeting

P1476

The critical role of bisphosphonates to target bone cancer metastasis: an overview

@en

P2093

Manish Kumar

http://www.w3.org/2001/XMLSchema#string

Prabhjot Kaur

http://www.w3.org/2001/XMLSchema#string

R S R Murthy

http://www.w3.org/2001/XMLSchema#string

Tejinder Singh

http://www.w3.org/2001/XMLSchema#string

Veerpal Kaur

http://www.w3.org/2001/XMLSchema#string

P2860

Biology of RANK, RANKL, and osteoprotegerin

Tumor self-seeding by circulating cancer cells

Actions of bisphosphonates in animal models of breast cancer

Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas.

Thematic review series: lipid posttranslational modifications. Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I

Normal bone anatomy and physiology

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

Synthesis and in vitro hydroxyapatite binding of peptides conjugated to calcium-binding moieties.

A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate.

Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment.

P304

1-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/1061186X.2014.950668

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Ravindra K Rawal

P577

2014-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25203856

http://www.w3.org/2001/XMLSchema#string